SCHEMBL21362563

SCHEMBL21362563

CN[C@@H](C)c1cc(=O)n(C)cc1-c1ccccc1C(=O)c1ccc(Cl)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.53
KMT2A Q03164 3/20 0.42
KDM4E B2RXH2 4/20 0.42
NR4A1 P22736 1/20 0.41
LMNA P02545 4/20 0.39
MAPT P10636 4/20 0.39
NPSR1 Q6W5P4 4/20 0.39
ALDH1A1 P00352 4/20 0.39
MEN1 O00255 2/20 0.39
PKM P14618 1/20 0.39
HPGD P15428 1/20 0.39
ALOX12 P18054 1/20 0.39
HTT P42858 4/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
USP2 O75604 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21362559 0.91 BRD4 (0.52) BRD4KMT2AKDM4ENR4A1LMNA
SCHEMBL21362103 0.87 BRD4 (0.46) BRD4KMT2AKDM4ENR4A1LMNA
SCHEMBL21352026 0.87 BRD4 (0.48) BRD4KMT2AKDM4ENR4A1LMNA
SCHEMBL21362018 0.84 BRD4 (0.44) BRD4KMT2AKDM4ENR4A1P2RX3
SCHEMBL21362518 0.77 BRD4 (0.45) BRD4KMT2AKDM4ENR4A1LMNA
SCHEMBL20157788 0.77 BRD4 (0.43) BRD4KMT2AKDM4ENR4A1LMNA
SCHEMBL21362517 0.76 BRD4 (0.40) BRD4KMT2AKDM4EP2RX3CNR2
SCHEMBL21362150 0.76 BRD4 (0.40) BRD4KMT2AKDM4EP2RX3CNR2
SCHEMBL21362149 0.75 BRD4 (0.40) BRD4KMT2AKDM4ELMNAALDH1A1
SCHEMBL18113379 0.75 POLB (0.42) BRD4KMT2AMAPTNPSR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed